Senior insider sale
Executive Chairman at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$31.96M
73.29K shares
What this filing means
LEIDEN JEFFREY M plans to sell 73.29K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $31.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/14/2025ACC: 0001950047-25-008867
DirectorOfficer· Executive Chairman
Since Feb 2026
73.29K
Shares to sell
$31.96M
Approx. market value
53.60K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/14/2025
53.60KTotal acquired53.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/14/2025 | Exercise of Stock Options Cash | 53.60K | — |
| Total | 53.60K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
19.69K
Market value
$8.67M
11/13/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
53.60K
Market value
$23.29M
11/14/2025
Total
Units
73.29K
Value
$31.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/13/2025 | 19.69K | $8.67M | — | Completed |
| Planned — Approximate Date | ||||
11/14/2025 | 53.60K | $23.29M | NASDAQ | Planned |
| Total | 73.29K | $31.96M | ||